News

Latest News:

mc2_news-image-icon-05

Almirall and MC2 Therapeutics enter a License, Collaboration and Commercialization Agreement for European Rights to WYNZORA® Cream for treatment of Plaque Psoriasis

POSTED: February 17, 2021

In this collaboration Almirall will commercialize Wynzora® Cream for treatment of plaque psoriasis in Europe and MC2 Therapeutics will be responsible for manufacturing and supply.

Upcoming Events:

There are no upcoming events at the moment.

READ MORE >

© mc2 therapeutics 2020